Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-02Clinical Trial Update: Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy [Phase 4]
Phase 4 clinical trial comparing levofloxacin-based sequential therapy versus standard triple therapy for eradication of Helicobacter pylori…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion [Phase 2, Phase 3]
Clinical trial update noting the completion of a Phase 2/3 study comparing Pylopass to placebo in Helicobacter pylori carriers with mild ind…
-
CLINICAL_TRIALS withdrawal · 2015-01-15Clinical Trial Update: An Open-Label Trial Of Reduced- Dose Pylera, Amoxicillin, and Esomeprazole in the Treatment Of Helicobacter Pylori Infection [Phase 4]
A Phase 4 open-label trial of reduced-dose Pylera with amoxicillin and esomeprazole for Helicobacter pylori infection has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: POCone-UBiT-IR300 Pediatric Comparison Study [Phase 4]
A Phase 4 pediatric comparison trial of POCone-UBiT-IR300 for Helicobacter pylori infection completed, with results posted in January 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Gut Hormone, Nociceptors, Neurotrophic Factors Expression in Functional Dyspepsia
A completed clinical study examining the expression of gut hormones, nociceptors, and neurotrophic factors in functional dyspepsia, includin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-12-19FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2014-12-19FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)
FDA approved a supplemental application for esomeprazole strontium from R2 Pharma, LLC, granting approval of this salt form under NDA 202342…
-
FDA approval · 2014-12-19FDA Approved: PREVACID — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for PREVACID (lansoprazole) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: The Impact of Addition of Curcumin for 10 Days Triple Therapy, on the Eradication Rate of Helicobacter Pylori Infection [NA]
This clinical trial update evaluates whether adding curcumin to a 10-day triple therapy improves eradication of Helicobacter pylori infectio…
-
FDA approval · 2014-12-12FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)
The FDA approved Apotex Corp's supplemental application for a generic omeprazole product.
-
CLINICAL_TRIALS trial_result · 2014-11-26Clinical Trial Update: A Phase Ⅲ Clinical Trial With Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children [Phase 3]
A Phase III trial of an oral recombinant Helicobacter pylori vaccine in Chinese children has completed.
-
FDA approval · 2014-10-31FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole from Sandoz Inc, authorizing continued manufacture and sale of a generic omeprazole p…
-
FDA approval · 2014-10-31FDA Approved: OMEPRAZOLE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's generic omeprazole, establishing bioequivalence to the reference product and authorizing its marketing in the United…
-
FDA approval · 2014-10-28FDA Approved: IDKIT HP ONE — Supplemental Application (Meridian Bioscience Israel Ltd)
FDA approved a supplemental application for IDKIT HP ONE, a diagnostic test kit using citric acid anhydrous and 13C urea, developed by Merid…
-
FDA label_change · 2014-10-15FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC to update the labeling.
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection [Phase 4]
This document describes a Phase 4 clinical trial evaluating an acetylcysteine-containing triple therapy as first-line treatment for Helicoba…
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection [Phase 4]
A Phase 4 randomized trial comparing levofloxacin plus a bismuth-containing regimen versus quadruple therapy as second-line treatment for re…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: RCT: Triple vs Sequential vs Concomitant Therapy H Pylori [Phase 4]
This document reports the completed Phase 4 randomized trial comparing triple therapy, sequential therapy, and concomitant therapy regimens …
-
FDA approval · 2014-05-28FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the combination drug bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride,…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Anti-H. Pylori Effect of Deep See Water [Phase 3]
A Phase 3 trial conducted by National Taiwan University Hospital evaluated the effect of deep sea water on Helicobacter pylori infection; th…
-
CLINICAL_TRIALS research · 2014-04-30Clinical Trial Update: Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy
This entry provides a clinical trial update on the Endofaster test for detecting Helicobacter pylori in patients who are on proton pump inhi…
-
CLINICAL_TRIALS withdrawal · 2014-04-29Clinical Trial Update: A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide [Phase 2]
A Phase 2 randomized, open-label trial evaluating addition of acetazolamide to the standard triple regimen for Helicobacter pylori infection…
-
CLINICAL_TRIALS research · 2014-04-28Clinical Trial Update: Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections
A clinical trial update discusses gamma-glutamyl transferase as a potential diagnostic marker for Helicobacter pylori infections.
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Safety and Efficacy Study of a Non-antibiotic Treatment for the Eradication of Helicobacter Pylori [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a non-antibiotic treatment for eradication of Helicobacter pylori was terminated, with results posted …
-
FDA approval · 2014-02-25FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) from Covis Pharma US, Inc. The approval updates the labeling for…